EIG
BIVV

EdgePoint Investment Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

EdgePoint Investment Group’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,230,809
Closed -$174M – 48
2017
Q4 		$174M Buy
+3,230,809
New +$177M 2.49% 15

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

EdgePoint Investment Group's BIVV Position: Q1 2018 in Review

EdgePoint Investment Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 3,230,809 shares — an estimated $174M sold.

EdgePoint Investment Group first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $174M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • EdgePoint Investment Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • EdgePoint Investment Group sold 3,230,809 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $174M.
  • EdgePoint Investment Group first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • EdgePoint Investment Group's Bioverativ Inc. Common Stock position peaked at $174M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on EdgePoint Investment Group's 13F filing for Q1 2018, filed 14 May 2018.